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Sary Secretary component (SC) is expressed basolaterally as a transmembrane protein (pIg receptor) on
secretory epitheial cells. As pIg receptor it plays a central role in humoral immunity by mediating the external
translocation ofdimeric IgA and pentameric IgM. A few case reports have suggested that reduced or absent SC
protein expression is associated with diarrhoeal disease, but there is no convincing evidence that a primary pIg
receptor deficiency can occur. In this study the relative presence of SC mRNA was determined by Northern
blot analysis and related to immunohistochemically determined SC protein expression in 33 colorectal
adenomas (31 patients) with increased risk ofdeveloping sporadic colorectal cancer, as well as in 19 colorectal
carcinomas from 19 patients with such sporadic tumours. In the adenomas, SC mRNA levels were positively
related to SC protein expression; both mRNA and SC protein were negatively related to histological grade.
Similarly, SC mRNA levels tended to be related to the SC protein expression in the carcinomas. SC mRNA
was detected in all adenomas, and only two of ten carcinomas (10.5%) deemed to be SC deficient by
immunohistochemistry also lacked SC mRNA expression, suggesting diallelic alterations in the SC-encoding
gene (locus PIGR). This possibility agreed with Southern blot analysis performed on a separate sample of 32
other colonic carcinomas in which the diallelic loss of D1S58 (which exhibits a close linkage centromerically to
PIGR) was caculated to be 6.4%. Together these findings suggested that reduced SC protein expression in
colorectal adenomas might be a transcriptional defect reflecting the degree ofcellular dysplasia, whereas absent
SC protein expression in colorectal carcinomas might also involve post-transcriptional defects and occasional
diallelic gene deletions representing late events in carcinogenesis.
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Human secretory component (SC) is expressed as a
transmembrane protein (pIg receptor) of approximately
100 kDa basolaterally on secretory epithelial cells (Mostov
and Blobel, 1982). It mediates the external transport of
dimers and higher polymers of IgA (pIgA) as well as
pentameric IgM (pIgM) across secretory epithelia (reviewed
by Brandtzaeg et al., 1994). This function is unique for
transmembrane SC, which is responsible for a daily
translocation of approximately 40 mg secretory IgA
(SIgA) kg-' body weight to the intestinal juice (Conley and
Delacroix, 1987). Immunohistochemical studies (Brandtzaeg,
1985) and Northern blot analyses (Krajbi et al., 1989) have
demonstrated abundant expression of SC by glandular
epithelia, particularly by the intestinal crypt cells.
SC protein expression is significantly reduced in dysplastic
epithelium as seen in ulcerative colitis (Rognum et al., 1982a).
One immunodeficient case showing virtually undetectable
SIgA in jejunal fluid (Nussinson et al., 1986) and two cases
lacking SIgA in both saliva and jejunal fluid (Krakuer et al.,
1975; Strober et al., 1976) have been reported. However,
absence of SC production was not documented and
compensatory secretion of pIgM was suggested as discussed
elsewhere (Brandtzaeg et al., 1991). In fact re-examination of
one of the patients decribed by Strober et al. (1976) conluded
that the SC deficiency had been transient rather than
acquired (Plaut and Ridker, 1992). It has been concluded
that there is no convincing documentation that a primary SC
deficiency may exist (Brandtzaeg et al., 1991), which agrees
with the notion that the pIg receptor has a crucial protective
role at the mucosal surfaces. SC expression is often up-
regulated in diseased secretory tissue (Scott et al., 1981;
Valnes et al., 1984; Thrane et al., 1992), probably reflecting a
modulating effect of various cytokines as shown in vitro
(Sollid et al., 1987; Kvale et al., 1988; Phillips et al., 1990;
Krajbi et al., 1993; Piskurich et al., 1993).
Colorectal tumours were found to display reduced
expression of SC protein being negatively related to the
grade of dysplasia in adenomas (Isaacson, 1982; Rognum et
al., 1982b) and to the histological grade as well as Dukes'
stage in colorectal carcinomas (Rognum et al., 1980; Koretz
et al., 1994). These observations suggested that SC might be a
marker for the malignant potential of colonic adenomas.
Similar studies on SC mRNA expression were not possible
until the cloning of human transmembrane SC cDNA had
been achieved (KrajZi et al., 1989; 1991). The aim of the
present study was to investigate the mRNA-protein
relationship for SC in colorectal adenomas and carcinomas.
Mateials and methods
Patients groups
Northern blot analysis and inmunohistochemistry Thirty-three
colorectal adenomas, all exceeding 1 cm in diameter, were
collected during endoscopic examination of 31 patients (mean
age 70 years, range 51-82 years) with gastrointestinal
complaints. Clinicopathological information is shown in
Table I. Faecal blood was detected in 12 of the patients
(39%), three (10%) had first-degree relatives with sporadic
colorectal carcinoma, four (13%) had first-degree relatives
with breast cancer, two (6%) had first-degree relatives with
genital cancer, and five (16%) had first-degree relatives with
other cancers (each patient exhibited at least one of the
associations listed above). As a group these patients were
deemed to be at higher risk of developing sporadic colorectal
cancer than other similarly aged adenoma patients (Hoff et
al., 1986). The tendency to adenoma formation (followed
colonoscopically for 3 years) showed an increasing median
number of tumours (from 3.1 to 5.5) with an initial average
diameter of 14 mm measured by an endoscopic measuring
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Tabk I Expression of SC mRNA and protein, and clinicopathological variables in 33 colorectal
adenomas from 31 patients
Patient Dominating SC mRNA Grade of Bowel
no. Age Sex SC protein pattern' expressionb dysplasid location
1 62 F 0 0.23 Severe Sigmoid colon
2 75 M 0 0.50 Severe Caecum
3 55 F 1 0.90 Severe Caecum
4 82 M 1 0.70 Severe Rectum
5 70 F 1(0-1) 1.04 Severee Sigmoid colon
6 62 F 1(0-1) 1.85 Severe Sigmoid colon
7ad 70 F 1(0-1) 0.86 Moderate Rectum
8 71 F 1(0-2) 0.97 Severe Rectum
9 71 M 1(0-2) 0.83 Severe Sigmoid colon
7bd 70 F 1(0-2) 0.64 Severe Rectum
10 55 F 1(0-2) 1.19 Moderate Descending colon
11 67 M 1(1-2) 1.21 Severee Sigmoid colon
12 63 M 1(1-2) 0.79 Severee Sigmoid colon
13 65 M 2(0-2) 3.60 Moderate Descending colon
14 58 M 2(0-3) 1.06 Severe Sigmoid colon
15 52 M 2(0-3) 2.58 Severe Rectum
16 71 F 2(0-3) 2.43 Moderate Sigmoid colon
17 70 F 2(1-2) 1.30 Severe Sigmoid colon
18 61 M 2(1-2) 2.32 Moderate Ascending colon
19 69 F 2(1-2) 2.55 Moderate Rectum
20 64 M 2(1-2) 0.62 Slight Descending colon
21 66 M 2(1-3) 1.17 Severe Sigmoid colon
22 70 F 2 2.05 Severe Sigmoid colon
23 51 M 2 1.95 Severe' Sigmoid colon
24 66 F 2 1.48 Severe' Rectum
25 65 F 2 2.00 Moderate Sigmoid colon
26 61 M 2 1.50 Moderate Sigmoid colon
27 66 M 2 12.1 Moderate Sigmoid colon
28 66 M 2 2.03 Moderate Rectum
29 65 M 2 14.5 Moderate Rectum
7cd 70 F 3(2-3) 1.19 Moderate Sigmoid colon
30 70 M 3(2-3) 4.00 Moderate Transverse colon
31 65 M 3 1.04 Moderate Sigmoid colon
aScoredsemiquantitatively from 0 -3, with 3 representing theimmunofluorescence stainingpattern of
normal colonic epithelium. The adenomas revealing a heterogeneous staining pattern were scored
according to the dominating pattern, the range ofscores within the same tumour section being reported
in parenthesis. bFor each adenoma a value of SC mRNA level was cakulated relative to the
correspondingf-actin mRNAlevel. CJass and Sobin (1989). dThre specimens (a-c) were obtained from
three separate adenomas in this patient. 'Adenomas with only focal severe dysplasia.
Table I Expression of SC mRNA and protein, and clinicopathological variables in 19 colorectal
carcinomas
Patient Dominating SC mRNA Grade of Dukes' Bowel
no. Age Sex SC protein pattern' expressionb differentiation staged location
1 881 M 0 0.2 Moderate B Ascendingcolon
2 37 M 0 1.4 Moderate B Rectum
3 62 F 0 0.4 Moderate C Rectum
4 71 M 0 0 Moderate D Splenic flexure
5 78 M 0 0 Moderate D Rectum
6 69 M 0 0.6 Moderate D Rectum
7 26 F 0 0.5 Moderate D Rectum
8 74 M 0 0.3 Poor C Hepatic flexure
9 86 F 0 1.9 Poor D Sigmoid colon
10' 44 F 0(0-1) 0.9 Moderate B Rectum
11 74 F 1(1-2) 0.7 Well B Sigmoid colon
12 65 M 1(1-2) 1.8 Moderate B Rectum
13 67 F 1 0.5 Moderate B Rectum
14 80 F 1 1.3 Moderate C Caecum
15 69 F 1 0.5 Poor D Hepatic flexure
16 80 F 2(0-2) 1.7 Moderate D Sigmoid colon
17 74 F 2 2.7 Well A Rectum
18 62 M 2 1.2 Moderate A Rectum
19 68 F 3 2.2 Moderate D Caecum
aScoredsemiquantitatively from 0-3, with 3 representing the immunofluorescencestainingpatternin normal
epithelia (see Materials and methods). The carcinoma revealing a heterogeneous staining pattern were scored
according to the dominating pattern, the range of scores within the same tumour section being reported in
paranthesis. bFor each carcinoma a value ofSC mRNA level was cakulated relative to the respectivef-actin
mRNA level. cMorsonand Sobin(1976).dDukesand Bussey(1958). SThe tumourfrom thispatientwas studied
with respect to possible intratumour heterogeneity on the basis ofsamples taken from four different locations.SC e n r- ei cdoar.c banoers
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probe (Hofstad et al., 1992). Twenty-six (79%) of the 33
adenomas were located in the most typical area for the
development of colorectal cancer in this age group, rectum
and sigmoid colon (reviewed by Correa and Haenszel, 1978).
Histological examination showed severe grade of dysplasia in
18 (55%) and intramucosal carcinoma in one (3%) of the
adenomas.
Nineteen adenocarcinomas were sampled from 19 patients
(mean age 66 years, range 37-86 years) with sporadic
colorectal cancer. Clinicopathological information is shown
in Table II.
Southern blot analysis Another larger adenocarcinoma sample
(32 patients; mean age 71 years, range 33-88 years) for
which DNA was available, was randomly selected from a
separate collection of 231 colorectal cancers removed during
laparotomy (Meling et al., 1993). This sample was used for
restriction fragment length polymorphism (RFLP) analysis of
allelic alterations at the D1S58 locus of chromosome 1.
Clinicopathological information is given in Table MII.
Tissue specimens
Northern blot analysis Immediately after removal of the
colorectal adenomas, one tissue sample (exceeding 10 mg wet
weight) from each tumour was divided into two pieces that
were frozen in liquid nitrogen and thereafter stored at -70°C
for subsequent RNA extraction or histological/immunohisto-
chemical evaluation respectively.
Similarly, tissue samples from each colonic carcinoma,
were obtained by endoscopy and treated as above. One
carcinoma was studied with regard to possible intratumour
heterogeneity by sampling from four different locations.
Tabl m RFLP pattern for DlS58 and clinicopathological
mononucl
Southern blot analysis Cell suspensions were prepared as
described previously (Meling et al., 1993) and stored in 70%
ethanol at 4°C until DNA extraction was performed.
Probes and labelling
Northern blot analysis was performed with the entire 2.9 kb
human SC cDNA (Kraj6i et al., 1991) and a PstI fragment
from chicken I-actin cDNA (Cleveland et al., 1980).
Southern blot analysis was performed with a 5.0 kb MspI
fragment from the polymorphic DNA sequence pYNZ23
(locus D1S58) (Nakamura et al., 1987), which exhibits a close
linkage centromerically to the SC gene (locus PIGR)
(lods+ 5.06 at 0,=0.06) (Krajci et al., 1992). The probes
were labelled with [(-32PJdCTp (110 TBq mmol-', Amer-
sham, Buckinghamshire, UK) by application of random
primers (Feinberg and Vogelstein, 1984).
RNA extraction and Northern blot analysis
Extraction of total RNA and Northern analysis was
performed as described previously (Krajci et al., 1989).
Autoradiography was accomplished at -70°C, with X-ray
film (Hyperfilm-MP Amersham) and intensifying screens
(Kodak X-Omatic Super Rapid, Eastman Kodak, NY,
USA) for less than 1 day with the 1-actin probe and for
3-5 days with the SC probe.
Densitometric analysis ofNorthern blot autoradiograms
Suitably exposed autoradiograms were analysed for optical
density (OD) with a 2202 Ultroscan Laser Densitometer
(LKB, Bromma, Sweden). For each adenoma and carcinoma
variables in 32 colorectal carcinomas and peripheral blood
:ear cells
Patient RFLP Heterozygous Alleic Grade of Dukes' Bowel
no. Age Sex PBMCb Carcinoma informative loss differentiationc staged location
75 F A1A2 Al + + Moderate D Rectum
2 62 F A1A2 Al + + Moderate A Sigmoid colon
3 64 M AlA2 A2 + + Moderate B Sigmoidcolon
4 81 F AlA2 A2 + + Poor B Caecum
5 33 M AlA2 NDV + +f Poor C Rectum
6 78 M AlA2 A1A2 + - Well B Rectum
7 68 F A1A2 A1A2 + - Well C Rectum 8 63 M A1A2 A1A2 + - Moderate C Rectum 9 77 F A1A2 A1A2 + - Moderate B Caecum
10 76 M A1A2 AlA2 + - Moderate B Caecum 11 79 F A1A2 A1A2 + - Moderate C Rectum 12 85 M A1A2 A1A2 + - Moderate B Rectum 13 73 F AlA2 A1A2 + - Moderate B Rectum 14 61 M A1A2 AlA2 + - Moderate B Rectum 15 70 F A1A2 A1A2 + - Moderate B Right flexure 16 74 F A1A2 AlA2 + - Moderate B Rectum 17 88 M A1A2 A1A2 + - Moderate B Sigmoid colon 18 65 F AlA2 AlA2 + - Moderate C Rectum 19 59 M A1A2 A1A2 + - Poor C Rectum 20 68 M A1A2 A1A2 + - Poor B Sigmoid colon 21 51 F A1A2 AlA2 + - Poor B Rectum
22 74 F A1A2 A1A2 + - Poor C Rectum 23 88 F A1A2 A1A2 + - Poor C Right flexure 24 65 F Al Al - - Well B Right flexure 25 84 M Al Al - - Moderate C Ascendingcolon 26 61 F Al Al - - Moderate B Caecum 27 58 M Al Al - - Moderate B Rectum 28 78 F A2 A2 - - Moderate D Caecum 29 77 M A2 A2 - - Moderate B Sigmoid colon 30 70 F Al Al - - Poor C Rectum 31 82 F Al Al - - Poor B Sigmoid colon 32 80 M A2 A2 - - Poor A Caecum
Restricionfragment length polymorphism (alles Al and A2 are represented by the 5.0kb and 4.5kb PvuH fragment on Southemblots respectively). bPeripheral blood mononuclear cells. cMorson and Sobin (1976). dDukes and Bussey (1958). eNot detectable. fDiallelic loss.SC expression in colorectal humours
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a value of SC mRNA level uA-as calculated relative to the
respectix-e fl-actin mRNA lexel. Levels of mRNA x-ere
assigned a score of 'reduced' and 'increased relative to the
median of the whole sample material.
Southern blot analysis of RFLP
Southern blot analvsis of PvuII-digested genomic DNA
(10 ,ig) from colorectal carcinomas and from peripheral
white blood cells of the same patients (Meling et al.. 1993).
was performed as described preViously (Krajci et al.. 1991).
The membranes were exposed to X-ray film with an
intensif-ing screen for 5 8 da-s at -70-C.
Immunohistochemical staining and evaluation
The biopsy- samples were placed directlx from -70-C into
9600 ethanol at 4-C and further processed for low-
temperature paraffin embedding (Brandtzaeg. 1974). One
section cut at 6 gim from each tissue block was subjected to
direct immunoflourescence staining for 20 h with a fluor-
escein isothiocvanate (FITC)-labelled sheep anti-SC conju-
gate (Brandtzaeg. 1981). To control for morphology. an
adjacent section was stained by a trichrome routine method
with haematoxvlin. azofloxine and saffron (Stave and
Brandtzaeg. 1977).
Observations w-ere performed by an Aristoplan fluores-
cence microscope (Leitz. Germany) equipped with an HBO
100 W lamp for excitation of FITC (green) emission. A
Ploem-type epi-illuminator Aas used for narrow-band
excitation and filtration. The intensity of epithelial SC
fluorescence w-as scored on an arbitrary semiquantitative
scale from 3 (referring to the pattern of normal colonic
epithelium) to 0 (indicating virtual lack of staining) (Rognum
et al.. 1980). Tissue samples with heterogenous staining were
scored according to the dominating pattern. the range of
scores within the same tumour section being recorded as well.
Histological grading
The colorectal adenomas and carcinomas u-ere graded
histologicallv by one obserner as showing slight. moderate
or severe dysplasia (Jass and Sobin. 1989) and as being well.
moderately or poorlx differentiated (Morson and Sobin.
1976) respectively. The adenomas with only focal lesions of
severe dvsplasia were classified together with those showing
more extensive sexere dysplasia (Table I).
Statistical analysis
Expression of SC mRNA. although semiquantitatively deter-
mined. A-as the onlv trulv measured vaniable in this inv-estiga-
tion: fluorescence scores and histological tumour grades wxere
based on subjective ranking. Statistical analyses wxere therefore
adjusted to the limitations gixen for the ordinarx scale (Stevens.
1946) as provided by non-parametric two-tailed rank methods.
Group comparisons were based on the Mann-Whitnev U-test
(Siegel. 1956). Epithelial SC staining was grouped in txxo
categories (0 - 1 and 2 -3) for adenomas and (0 and 1 -3) for
the carcinomas. The histological tumour grade was assigned as
slight moderate' or 'severe' for the adenomas and 'slight-
moderate' or poor' for the carcinomas. P-values of0.05 or less
x ere considered statistically significant. The sample represent-
ing the median value with respect to mRNA expression was not
included in the group comparisons.
Results
Colorectal adenomas
Immunofluorescence staining patterns The expression of SC
was heterogeneous in 20 and homogeneous in 13 adenoma
samples (Table I). The staining intensity decreased with
increasing grade of dysplasia (P<0.01) and SC A-as
undetectable in two cases (Figures 1 and 2a). In general.
IgA-positive plasma cells w-ere detected in the vicinity of SC-
expressing tumour epithelial cells and the latter often
contained IgA as well (data not show-n).
SC mRNV4 in relation to immunofluorescence staining -
Northern blot analx-ses demonstrated SC mRNA in variable
amounts but with a constant size of approximatelx 3.8 kb
(Figure 3). Reduced SC mRNA levels were noted in 11 of the
12 adenomas that had an SC staining score of 0- 1. but only
in 4 of those 19 that had a score of 2-3 (Figure 4). This
difference A-as significant (PKK0.001).
SC mRNA in relation to histological tumour grade Reduced
SC mRNA levels were noted in 11 of the 17 adenomas With
severe but in only 5 of 15 tumours with slight-moderate
dysplastic changes (Figure 5). However. this trend did not
reach significance because of the small number of samples
(P=0.08).
Colorectal carcinonmas
Immunofluorescence staining patterns SC protein expression
was demonstrated in only 9 of the 19 tumours. four with a
heterogeneous pattern (Table II). The staining intensity
decreased With increasing grade of dvrsplasia. but this trend
did not quite reach significance because of the small number
of samples (P=0.06).
SC mRVA in relation to immunofluorescence staining SC
mRNA of normal size w-as detected in 17 of the tumours.
Reduced SC mRNA lexels wxere noted in sexen of the ten
tumours that had an SC staining score of 0. but onlv two of
them totallv lacked the specific message (Table II). Reduced
mRNA levels tended to be less common (txx-o cases) among
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Figure 1 Immunofluorescence scores for SC in colorectal
adenomas (n= 33) wxith different grades of dysplasia collected
from 31 patients with gastrointestinal complaints. The broken line
connects the median scores for SC protein expression. w-hich A-as
signficantlv lowxer in adenomas with sexere than with slight-
moderate dysplasia.SC expression i coorectal tumours
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Figure 3 Northern blot of SC mRNA from six colorectal
adenomas collected from six patients with gastrointestinal
complaints. Total RNA (10lug) u-as extracted. electrophoresed.
blotted onto nvlon membranes and hybridised with random
prime-labelled human SC cDN-A probe (top) and chicken fl-actin
cDNA probe (bottom) (specific activity 2 x 109c.p.m. ,ig DNA.
106c p m ml- hvbridisation solution). The patient numbers refer
to Table I.
Figure 2 Immunofluorescence staining for SC in colorectal
neoplasia. (A) Adenoma with moderate grade of dysplasia
(no.5. Table I). A heterogenous staining pattern is observed.
semiquantitatively scored as 1 and 3 in this part of the tumour.
(B) Carcinoma. moderatelv differentiated (no. 10. Table II). A
homogenous. negative staining pattern for SC (scored as 0) is
observed in this carcinoma (to the rig.ht). w-hereas the positive
staininz of normal colonic epithelium is shown to the left (scored
as 3).
the eight tumours that had an SC staining score of 1-3.
although there was no statistically significant difference
because of the small number of samples (P=0.07).
The four samples studied from a single carcinoma showed
a slightly heterogeneous immunofluoresence staining pattern
with intensity scores ranging from 0 to 1. but the mRNA
levels appeared to be similar.
z
a)
E
0
.
1 4
12
4,
3,
2
SC mRVA in relation to histological tumour grade Reduced
SC mRNA levels were noted in t-o of the three carcinomas
with poor but in onlE 7 of 15 tumours with slight-moderate
grade of differentiation. No statistical evaluation could be
performed because of the small number of poorly
differentiated tumours.
Southern analysis ofRFLP and allelic alterations at the D1S58
locus
Piull revealed a two-allelic poly-morphism for DlS58. namely
a 5.0 kb (allele Al) and a 4.5 kb (allele A2) fragment.
Twenty-two cases (22 32=69%) w-ere heterozvgous (infor-
mative) for polymorphism on locus DlS58. Heterozygous
loss (Figure 6) xwas demonstrated in four of these tumours
(18%). In one additional case (3/0o) loss of the D1S58 locus
was observed on both chromosome lq arms (Table III).
0
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/ 6
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Fluorescence score
Figure 4 Scatter diagram of relationship betw-een SC mRNA
and SC protein expression in 33 colorectal adenomas collected
from 31 patients with gastrointestinal complaints. The broken line
connects the median of SC mRNA levels. w-hich w-as significantly
reduced in adenomas with decreased fluorescence score for SC.
Discussion
This studv is the first attempt to analx se the relativ-e SC
mRNA expression in colorectal tumours. The increased risk
of cancer in adenomas is related to the grade of dysplasia. the
tumour size (Morson. 1974). the tendency of bleeding (Doran
and Hardcastle. 1982). the tumour number (Matek et al..
1985). the patient's age (The Cancer Registry of Norway.
1982). and the presence of mammary or uterine cancer in the
same patient or their first-degree relativ-es (Giacosa et al..SC expression in corectal umours
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Figure 5 SC mRNA expression in 33 colorectal adenomas with
different grades of dysplasia collected from 31 patients with
gastrointestinal complaints. The broken line connects the median
of scores of SC mRNA levels. w-hich tended to be decreased with
increasing seventy of dysplasia.
1987). Because the present adenoma patients fulfilled such
criteria. the examined adenomas (all with a diameter above
10 mm) could be considered as high-risk precancerous
lesions.
A significant positive relationship appeared between the
SC mRNA levels and the immunofluorescence staining score
for SC in the adenomas; this was consistent With the
observation that protein expression is generally related to
the amount of specific message. The expression of functional
SC in the adenomas u-as supported by the fact that the
tumour cells in general showed coexpression for SC and IgA
(data not shown). In keeping with previous studies (Isaacson.
1982: Rognum et al.. 1982b). an inverse relationship existed
between the grade of dysplasia and the staining for SC in the
adenomas and the same trend was apparent for SC mRNA.
SC protein expression in colorectal adenomas might therefore
reflect the rate of transcript and or the stability of specific
mRNA.
In the colorectal carcinomas there likeWise tended to be a
positiv-e relation between SC mRNA and SC staining:
however. 530'0 of the tumours showed verx faint or absent
SC staining. which could be explained by total lack of SC
mRNA in only two specimens. Several possibilities might
explain this discrepancy. Firstly. despite an apparentlv
normal RNA size as demonstrated bN Northern blot
analysis. the SC message in these tumours might be defective
in essential translation segments (Munroe and Jacobson.
1990: Falcone and Andrews. 1991) or contain aberrations
(frameshift mutations) leading to the synthesis of nonsense'
protein not recognisable by our polyclonal anti-SC reagent.
Such putative mutations could have occurred at the genomic
level or during processing of the primary transcript: their
detection would need further characterisation of SC mRNA
from these tumours. such as cloning and sequencing.
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Figure 6 Southern blot analysis of genomic DNA extracted from
colorectal carcinomas and distant normal mucosa. Allele changes
were detected on chromosome lq by the probe pYNZ23 (specific
activity 2 x l09c.p.m.yg DNA, 106c.p.m.ml-l hybridisation
solution) on PvuLI-digested blots. Genomic DNA (10pg) from
normal (N) and tumour (T) tissue of three constitutionally
heterozygous patients is shown. Patient 1 is heterozygous for this
locus and patient 2 has lost the 5.0 kb allele in the tumour.
whereas patient 3 has lost the 4.5 kb allele in the tumour.
Secondly. absent synthesis of SC protein might be due to
lack of regulatory factors involved in mRNA translation
regulation (Macejak and Sarnow, 1990; Perlmutter, 1990:
Ryazanov et al., 1991: Yoon and Donahue, 1992). Thirdly.
SC could be subjected to altered post-translational processing
(see below).
SC is a specialised transmembrane receptor protein
responsible for the translocation of J chain-containing pIgA
and pIgM across secretory epithelia (Brandtzaeg and Prydz.
1984). Studies of mutant rabbit SC have demonstrated that
the intracytoplasmic segment of SC is essential for its sorting
mechanism (reviewed by' Mostov. 1994). Altered post-
translational modifications, impaired phosphorylation (Ca-
sanova et al.. 1990) as well as different deletions of this
segment result in deviations from the normal trafficking route
or cause degradation of SC after endocytosis (Breitfeld et al.,
1990). Rognum et al. (1982a) observed that neoplastic colonic
epithelium with moderate or severe dysplasia sometimes
contained SC but showed no uptake of IgA. indicating a
defect in its pIg receptor function: this might reflect improper
post-translational processing of SC during malignant
development.
In tw-o carcinomas absent SC protein expression was
clearly explained by lack of specific message. which was
verified by repeated RNA extractions from parallel tumour
samples. Possible reasons for this lack of SC mRNA might be
found at the transcnrptional level. such as deletions of the SC
gene or its regulatory units or absence of protein factor(s)
essential for its transcnption. Putative deletions would have
to involve the SC-encoding gene (locus PIGR) on both
chromosomes to cause absent message. PIGR is located in the
lq31-q41 region (Davidson et al.. 1988: Krajci et al., 1991:
1992). which is involved in a large number of recombinantor-
ial events (Brito-Babapulle and Atkin, 1981). Using
poly-morphic DNA markers. Vogelstein et al. (1989)
demonstrated that allelic loss on chromosome lq occurs in
approximately' 25% of colorectal carcinomas: the correspond-
ing loss of both alleles would then occur at a frequency of
about 6%. When we analysed genomic DNA extracted from
colonic carcinomas for allelic alterations of locus Dl S58.
which exhibits a centromeric location of PIGR (Krajci et al..
1992). heterozygous loss of this allele was revealed in 18%
and loss of both alleles in 30 of the cases. The estimated
frequency of simultaneous loss of both alleles [(4 22):'+1 32]
would be more than 6% and might well account for at least
one of the two SC mRNA-negative tumour carcinomas.
Nevertheless, because the SC mRNA and RFLP analyses
A-ere performed on different carcinoma materials. it cannot be
excluded that the association between the frequency of SC
mRNA loss and the frequency of diallelic loss of locus D1S58
is coincidental.
In conclusion, the positive relationship between mRNA
and protein levels of SC observed in colorectal adenomas
seemed to be the case also for carcinomas which, however.SC
expr inh- I twomas
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often lacked detectable SC protein despite expressing some
SC mRNA. This difference was remarkable because 55% of
the adenomas showed a severe grade of dysplasia. Perhaps
cancer SC mRNA contained frameshift mutations and/or was
excluded from translation owing to lack of (or suppression
by) specific protein factor(s). Deletion of the PIGR locus on
both chromosomes seemed to be a relatively rare event. The
inverse correlation between immunofluorescence staining for
SC and grade of dysplasia in the adenomas suggested that
reduced SC mRNA expression takes place only late in the
carcinogenesis of colorectal neoplasia. A larger tumour
sample will have to be analysed to see whether transcription
and/or expression of the SC gene might provide information
on cellular dedifferentiation during tumour development in
the large bowel.
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